Peanut Allergy Treatment Sends Stock Up Sharply

732185581 = katjen|||

Markets have provided an impressive show of confidence during today’s session. They traded up mildly to start the day’s trading before being hit with the news investors were—supposedly—fearing all week: a pickup in US inflation, coupled with weakening sales data. The twin specter of inflation and earnings slowdown was widely cited as driving the recent market pullback, and stocks fell markedly on the news.

But then they simply resumed their upward climb. The month continues to provide unexpected results and dramatic swings in sentiment. And the higher volatility goes, the more news-based trading opportunities can beat average performances from more passive strategies.

Every trading day on our Top Performer blog, you can see highlights from the diverse strategic option set opened up by real-time stock news analytics.

DBV Technologies (DBVT): up on FDA consideration of Peanut Allergy Treatment

DBVT Stock Gains

DBV Technologies was up sharply today after announcing that the United States FDA agrees that available data support a forthcoming license application for using DBV Technology’s new peanut allergy treatment in children ages 4-11. About one million US children suffer from this often severe allergy.

DBVT is developing a broadly applicable immunotherapy “treatment platform,” known as Viaskin, which they hope can help patients suffering from a large variety of allergy conditions. Viaskin delivery treatments through intact skin, utilizing DBVT’s innovative “epicutaneous immunotherapy” approach.

They hope to eventually offer a diverse product lineup including Viaskin Peanut, Milk, an Egg. Investors bought the stock on heavy volume, driving it to initial gains above 40%. It has since consolidated to gains around 27%. The pharmaceutical development sector continues to be unmatched for 1-day hold time trades in recent weeks: regulatory announcements that most smaller investors could never hope to track manually drive rapid valuation shifts. A savvy approach to news-based trading is essential in this often volatile portion of the marketplace.

Diverse Plays, Great Profits: All in a single news day.

Our blog is a great place to start exploring the News Quantified platform. You can get a sense of the diversity of potential strategies that can be maximized using the News Quantified system. Whether you’re day trading or focused on longer hold times for a particular sector like blockchain, pharmaceuticals, or mining, News Quantified maximizes your potential returns.

We offer free tours of our platform, complete with some strategic tips, on a regular basis. Click the button below to register for an upcoming training with no cost whatsoever.

Big institutional investors have whole departments monitoring news events. News Quantified gives smaller investors a fighting chance.

Yes! Claim My Spot Now >>

Leave a comment